newsfilter
← Latest News
Business Wire·

Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches

Collaboration aligns with Charles River’s strategic commitment to building deeper client relationships and accelerating development with alternative methods Charles River Laboratories International, Inc. (NYSE:CRL)